Pfizer recalls Chantix smoking cessation drug for increased cancer risk due to high levels of nitrosamine


Pfizer is voluntarily recalling lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the risk of cancer.

     



READ SOURCE

See also  Best crypto wallets to use for Bitcoin: From Coinbase to Exodus

LEAVE A REPLY

Please enter your comment!
Please enter your name here